Mechanism of the inhibitory effect of zwitterionic drugs (levofloxacin and grepafloxacin) on carnitine transporter (OCTN2) in Caco-2 cells

被引:51
作者
Hirano, Takeshi [1 ]
Yasuda, Satoru [1 ]
Osaka, Yuki [1 ]
Kobayashi, Masaki [1 ]
Itagaki, Shirou [1 ]
Iseki, Ken [1 ]
机构
[1] Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Clin Pharmaceut & Therapeut, Kita Ku, Sapporo, Hokkaido 0600812, Japan
来源
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES | 2006年 / 1758卷 / 11期
关键词
L-carnitine; Caco-2; levofloxacin; grepafloxacin; OCTN2;
D O I
10.1016/j.bbamem.2006.07.002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
L-Carnitine plays an important role in lipid metabolism by facilitating the transport of long-chain fatty acids across the mitocbondrial inner membrane followed by fatty acid beta-oxidation. It is known that L-carnitine exists as a zwitterion and that member of the OCTN family play an important role in its transport. The aims of this study were to characterize L-carnitine transport in the intestine by using Caco-2 cells and to elucidate the effects of levofloxacin (LVFX) and grepafloxacin (GPFX), which are zwitterionic drugs, on L-carnitine uptake. Kinetic analysis showed that the half-saturation Na+ concentration, Hill coefficient and K-m value of L-carnitine uptake in Caco-2 cells were 10.3 +/- 4.5 mM, 1.09 and 8.0 +/- 1.0 mu M, respectively, suggesting that OCTN2 mainly transports L-carnitine. LVFX and GPFX have two pK(a) values and the existence ratio of their zwitterionic forms is higher under a neutral condition than under an acidic condition. Experiments on the inhibitory effect of LVFX and GPFX on L-carnitine uptake showed that LVFX and GPFX inhibited L-carnitine uptake more strongly at pH 7.4 than at pH 5.5. It was concluded that the zwitterionic form of drugs plays an important role in inhibition of OCTN2 function. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:1743 / 1750
页数:8
相关论文
共 37 条
  • [1] CARNITINE - METABOLISM AND FUNCTIONS
    BREMER, J
    [J]. PHYSIOLOGICAL REVIEWS, 1983, 63 (04) : 1420 - 1480
  • [2] Carnitine transporter OCTN2 mutations in systemic primary carnitine deficiency: A novel Arg169Gln mutation and a recurrent Arg282ter mutation associated with an unconventional splicing abnormality
    Burwinkel, B
    Kreuder, J
    Schweitzer, S
    Vorgerd, M
    Gempel, K
    Gerbitz, KD
    Kilimann, MW
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 261 (02) : 484 - 487
  • [3] Expression and localization of organic cation/carnitine transporter OCTN2 in Caco-2 cells
    Elimrani, I
    Lahjouji, K
    Seidman, E
    Roy, MJ
    Mitchell, GA
    Qureshi, I
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2003, 284 (05): : G863 - G871
  • [4] β-lactam antibiotics as substrates for OCTN2, an organic cation/carnitine transporter
    Ganapathy, ME
    Huang, W
    Rajan, DP
    Carter, AL
    Sugawara, M
    Iseki, K
    Leibach, FH
    Ganapathy, V
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (03) : 1699 - 1707
  • [5] GANPHAICHITR V, 1993, NUTRITION, V9, P246
  • [6] Kinetic modelling of passive transport and active efflux of a fluoroquinolone across Caco-2 cells using a compartmental approach in NONMEM
    González-Alvarez, I
    Fernández-Teruel, C
    Garrigues, TM
    Casabo, VG
    Ruiz-García, A
    Bermejo, M
    [J]. XENOBIOTICA, 2005, 35 (12) : 1067 - 1088
  • [7] Expression, localization, and function of the carnitine transporter OCTN2 (SLC22A5) in human placenta
    Grube, M
    Schwabedissen, HMZ
    Draber, K
    Präger, D
    Möritz, KU
    Linnemann, K
    Fusch, C
    Jedlitschky, G
    Kroemer, HK
    [J]. DRUG METABOLISM AND DISPOSITION, 2005, 33 (01) : 31 - 37
  • [8] CARNITINE TRANSPORT IN HUMAN INTESTINAL BIOPSY SPECIMENS - DEMONSTRATION OF AN ACTIVE-TRANSPORT SYSTEM
    HAMILTON, JW
    LI, BUK
    SHUG, AL
    OLSEN, WA
    [J]. GASTROENTEROLOGY, 1986, 91 (01) : 10 - 16
  • [9] THE STIMULATIVE EFFECT OF DIFFUSION POTENTIAL ON ENOXACIN UPTAKE ACROSS RAT INTESTINAL BRUSH-BORDER MEMBRANES
    HIRANO, T
    ISEKI, K
    MIYAZAKI, S
    TAKADA, M
    KOBAYASHI, M
    SUGAWARA, M
    MIYAZAKI, K
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1994, 46 (08) : 676 - 679
  • [10] THE INTESTINAL TRANSPORT MECHANISM OF FLUOROQUINOLONES - INHIBITORY EFFECT OF CIPROFLOXACIN, AN ENOXACIN DERIVATIVE, ON THE MEMBRANE POTENTIAL-DEPENDENT UPTAKE OF ENOXACIN
    HIRANO, T
    ISEKI, K
    SATO, I
    MIYAZAKI, S
    TAKADA, M
    KOBAYASHI, M
    SUGAWARA, M
    MIYAZAKI, K
    [J]. PHARMACEUTICAL RESEARCH, 1995, 12 (09) : 1299 - 1303